• Citer

A phase 1 study of Taxotere (RP 56976 NSC 628503) administered as a one hour intravenous infusion on a weekly basis

par Tomiak, E;Piccart-Gebhart, Martine ;Kerger, Joseph ;de Valeriola, Dominique ;Tueni, Elias;Lossignol, Dominique ;Sculier, Jean-Paul ;Lips, S;Le Bail, N;Bayssas, M
Référence 7th NCI-EORTC Symposium on New Drugs in Cancer Therapy(1992), Proceedings of the 7th NCI-EORTC Symposium on New Drugs in Cancer Therapy, Vol. 122
Publication Publié, 1992

Publication dans des actes

• Détails

Titre:	A phase 1 study of Taxotere (RP 56976 NSC 628503) administered as a one hour intravenous infusion on a weekly basis
Auteur:	Tomiak, E; Piccart-Gebhart, Martine; Kerger, Joseph; de Valeriola, Dominique; Tueni, Elias; Lossignol, Dominique; Sculier, Jean-Paul; Lips, S; Le Bail, N; Bayssas, M
Informations sur la publication:	7th NCI-EORTC Symposium on New Drugs in Cancer Therapy(1992), Proceedings of the 7th NCI-EORTC Symposium on New Drugs in Cancer Therapy, Vol. 122
Statut de publication:	Publié, 1992
Sujet CREF:	Cancérologie
	Pharmacologie
Langue:	Anglais